Vanguard Group
ELAN icon

Vanguard Group’s Elanco Animal Health ELAN Stock Holding History

Vanguard Group’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.09B Sell
48,059,731
-526,977
-1% -$11.5M 0.02% 677
2025
Q3 		$979M Buy
48,586,708
+759,623
+2% +$12.7M 0.01% 716
2025
Q2 		$683M Sell
47,827,085
-496,161
-1% -$5.8M 0.01% 852
2025
Q1 		$507M Sell
48,323,246
-437,731
-0.9% -$4.95M 0.01% 986
2024
Q4 		$590M Sell
48,760,977
-184,506
-0.4% -$2.41M 0.01% 942
2024
Q3 		$719M Sell
48,945,483
-502,330
-1% -$7M 0.01% 825
2024
Q2 		$714M Buy
49,447,813
+189,573
+0.4% +$3.03M 0.01% 788
2024
Q1 		$802M Sell
49,258,240
-210,397
-0.4% -$3.29M 0.02% 750
2023
Q4 		$737M Buy
49,468,637
+467,196
+1% +$5.29M 0.02% 759
2023
Q3 		$551M Buy
49,001,441
+362,152
+0.7% +$4.21M 0.01% 846
2023
Q2 		$489M Buy
48,639,289
+2,314,726
+5% +$21.5M 0.01% 937
2023
Q1 		$435M Buy
46,324,563
+632,725
+1% +$7.46M 0.01% 987
2022
Q4 		$558M Buy
45,691,838
+3,015,401
+7% +$37.6M 0.02% 817
2022
Q3 		$530M Buy
42,676,437
+200,259
+0.5% +$3.5M 0.02% 804
2022
Q2 		$834M Buy
42,476,178
+1,023,648
+2% +$24.2M 0.02% 620
2022
Q1 		$1.08B Buy
41,452,530
+650,715
+2% +$17.3M 0.03% 610
2021
Q4 		$1.16B Sell
40,801,815
-58,573
-0.1% -$1.82M 0.03% 606
2021
Q3 		$1.3B Sell
40,860,388
-1,658,702
-4% -$55.7M 0.03% 551
2021
Q2 		$1.47B Buy
42,519,090
+372,791
+0.9% +$12.3M 0.04% 513
2021
Q1 		$1.24B Buy
42,146,299
+414,237
+1% +$12.7M 0.03% 547
2020
Q4 		$1.28B Buy
41,732,062
+2,217,632
+6% +$67.7M 0.04% 499
2020
Q3 		$1.1B Buy
39,514,430
+2,389,161
+6% +$60.5M 0.04% 492
2020
Q2 		$796M Sell
37,125,269
-846,657
-2% -$18.7M 0.03% 575
2020
Q1 		$850M Buy
37,971,926
+3,894,200
+11% +$107M 0.04% 487
2019
Q4 		$1B Buy
34,077,726
+243,817
+0.7% +$6.63M 0.03% 543
2019
Q3 		$900M Buy
33,833,909
+1,891,646
+6% +$56.7M 0.03% 550
2019
Q2 		$1.08B Buy
31,942,263
+2,955,748
+10% +$96M 0.04% 495
2019
Q1 		$930M Buy
28,986,515
+22,735,630
+364% +$700M 0.04% 525
2018
Q4 		$197M Buy
6,250,885
+1,201,238
+24% +$39.3M 0.01% 1252
2018
Q3 		$176M Buy
+5,049,647
New +$178M 0.01% 1476

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Black Creek Investment Management
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group's ELAN Position: Q4 2025 in Review

Vanguard Group reduced its Elanco Animal Health (ELAN) stake by 1.1% in Q4 2025, selling an estimated $11.5M and leaving 48,059,731 shares worth $1.09B. The position accounts for 0.02% of the portfolio, ranked #677.

Vanguard Group first reported a position in ELAN in Q3 2018 and has held it in 30 quarters since. The position peaked at $1.47B in Q2 2021. 487 funds tracked by Wall St. Rank hold ELAN as of Q4 2025.

  • Vanguard Group held 48,059,731 shares of Elanco Animal Health worth $1.09B as of Q4 2025.
  • Vanguard Group sold 526,977 Elanco Animal Health shares in Q4 2025, an estimated $11.5M.
  • Elanco Animal Health made up 0.02% of Vanguard Group's portfolio in Q4 2025, its #677 holding.
  • Vanguard Group first reported a position in Elanco Animal Health in Q3 2018 and has held it in 30 quarters since.
  • Vanguard Group's Elanco Animal Health position peaked at $1.47B in Q2 2021.
  • 487 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.